KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Operations: 2009-2025

Historic Cash from Operations for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $405.0 million.

  • Bausch Health Companies' Cash from Operations changed negligibly% to $405.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 8.66%. This contributed to the annual value of $1.6 billion for FY2024, which is 54.75% up from last year.
  • Latest data reveals that Bausch Health Companies reported Cash from Operations of $405.0 million as of Q3 2025, which was up 40.14% from $289.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Cash from Operations high stood at $601.0 million for Q4 2024, and its period low was -$1.3 billion during Q3 2022.
  • In the last 3 years, Bausch Health Companies' Cash from Operations had a median value of $289.0 million in 2025 and averaged $321.3 million.
  • Within the past 5 years, the most significant YoY rise in Bausch Health Companies' Cash from Operations was 1,879.17% (2022), while the steepest drop was 323.94% (2022).
  • Bausch Health Companies' Cash from Operations (Quarterly) stood at $24.0 million in 2021, then skyrocketed by 1,879.17% to $475.0 million in 2022, then dropped by 17.89% to $390.0 million in 2023, then spiked by 54.10% to $601.0 million in 2024, then remained steady at $405.0 million in 2025.
  • Its Cash from Operations was $405.0 million in Q3 2025, compared to $289.0 million in Q2 2025 and $211.0 million in Q1 2025.